NRC Eyes SHINE's License Shift to Chrysalis Entity
Published Date: 3/6/2026
Notice
Summary
SHINE Technologies wants to move its license for a medical isotope facility to a new company called SHINE Chrysalis, with a new parent company in charge. The Nuclear Regulatory Commission is reviewing this change and asking the public to share their thoughts or request a hearing by late March or early April 2026. This switch won’t affect the facility’s operations or costs but updates who officially holds the license.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in